Karo Bio and Pfizer Form Research Collaboration to Discover and Develop ROR-Gamma Modulators
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 1 (Table of Contents)
Published: 18 Jan-2012
DOI: 10.3833/pdr.v2012.i1.1671 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
After announcing its intention to spin-off its preclinical activities in October 2011, Swedish biotech Karo Bio has formed a research collaboration with Pfizer to advance its ROR-gamma (retinoic acid-related orphan receptor gamma) drug discovery programme for autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and psoriasis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS